Large-scale testing (Phase 3)Study completedNCT04978597What this trial is testingEarly ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study)Who this might be right forParkinson Bial - Portela C S.A. 410
Early research (Phase 1)Study completedNCT01449513What this trial is testingPEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal MicroscopyWho this might be right forActinic Keratosis LEO Pharma 24
Early research (Phase 1)Ended earlyNCT00979576What this trial is testingBIBF 1120 in Combination With Pemetrexed in Advanced Non Small Cell Lung Cancer (NSCLC)Who this might be right forCarcinoma, Non-Small-Cell Lung Boehringer Ingelheim 19
Early research (Phase 1)Study completedNCT01367535What this trial is testingEffects of MNTX on CYP450 2D6 in Metabolizers of DextromethorphanWho this might be right forHealthy Adults Bausch Health Americas, Inc. 54
Early research (Phase 1)Study completedNCT04082325What this trial is testingStudy Investigating the Safety and Tolerability of Lu AF88434 in Healthy Young MenWho this might be right forHealthy H. Lundbeck A/S 68
Large-scale testing (Phase 3)Ended earlyNCT04857840What this trial is testingRandomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH)Who this might be right forHypertension (HTN) Quantum Genomics SA 419
Large-scale testing (Phase 3)Study completedNCT00350636What this trial is testingA Comparison of a New Drug to Treat Overactive Bladder vs. PlaceboWho this might be right forOveractive Bladder Watson Pharmaceuticals 789
Large-scale testing (Phase 3)Study completedNCT01012765What this trial is testingEffect of Indacaterol on Inspiratory Capacity (IC)Who this might be right forChronic Obstructive Pulmonary Disease Novartis Pharmaceuticals 173
Large-scale testing (Phase 3)Study completedNCT00409851What this trial is testingOne Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With HypertensionWho this might be right forHypertension Novartis 1,293
Not applicableStudy completedNCT04002102What this trial is testingOpen-Label Placebos to Treat Fatigue in Multiple SclerosisWho this might be right forMultiple SclerosisFatigue University of Alabama at Birmingham 48
Early research (Phase 1)Ended earlyNCT03979820What this trial is testingA Study in Healthy People to Test How Combining BI 1467335 and Tyramine Affects Blood PressureWho this might be right forHealthy Boehringer Ingelheim 53
Early research (Phase 1)Study completedNCT02068690What this trial is testingSafety, Tolerability, and Pharmacokinetics of Single Doses BI 425809Who this might be right forHealthy Boehringer Ingelheim 83
Large-scale testing (Phase 3)Looking for participantsNCT07219420What this trial is testingEvaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis UCB Biopharma SRL 320
Early research (Phase 1)Study completedNCT04926051What this trial is testingAssess the Safety, Tolerability and Drug Levels of BMS-986172 in Healthy and Obese Participants, Including an Assessment of the Effects of Food on BMS-986172 AbsorptionWho this might be right forHealthy Participants Bristol-Myers Squibb 40
Large-scale testing (Phase 3)Study completedNCT01036139What this trial is testingEfficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's DiseaseWho this might be right forParkinson's Disease Bioprojet 268
Testing effectiveness (Phase 2)Study completedNCT00738595What this trial is testingPhase II Study to Evaluate the Effectiveness of EVT 302 in Smoking Cessation.Who this might be right forSmoking Cessation Evotec Neurosciences GmbH 400
Large-scale testing (Phase 3)Study completedNCT01440101What this trial is testingNatalizumab (BG00002, Tysabri) Study in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)Who this might be right forMultiple Sclerosis Biogen 106
Post-approval studies (Phase 4)Study completedNCT04085172What this trial is testingTAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)Who this might be right forAttention Deficit Hyperactivity Disorder Shire 396
Testing effectiveness (Phase 2)Study completedNCT02063295What this trial is testingAn Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic InjuryWho this might be right forObesityOver-weightHypothalamic Injury+1 more Zafgen, Inc. 14
Large-scale testing (Phase 3)Study completedNCT03446001What this trial is testingSafety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label TreatmentWho this might be right forAlzheimer Disease TauRx Therapeutics Ltd 598